Baker Bros. Advisors LP Insmed Inc Transaction History

Baker Bros. Advisors LP

$9.86 Billion
Q2 2025

A detailed history of Baker Bros. Advisors LP transactions in Insmed Inc stock. As of the latest transaction made, Baker Bros. Advisors LP holds 7,712,900 shares of INSM stock, worth $1.13 Billion. This represents 7.87% of its overall portfolio holdings.

Number of Shares

7,712,900

Previous 5,380,626 43.35%

Holding current value

$1.13 Billion

Previous $410 Million 89.1%

% of portfolio

7.87%

Previous 4.89%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$64.81 - $105.9 $151 Million - $247 Million	2,332,274 Added 43.35%	7,712,900 $776 Million
Q1 2025 May 15, 2025	BUY	$65.25 - $83.83 $24.4 Million - $31.3 Million	373,763 Added 7.47%	5,380,626 $410 Million
Q4 2024 Feb 14, 2025	BUY	$66.29 - $76.63 $39.2 Million - $45.3 Million	590,945 Added 13.38%	5,006,863 $346 Million
Q3 2024 Nov 14, 2024	BUY	$62.0 - $79.01 $52.1 Million - $66.4 Million	839,880 Added 23.49%	4,415,918 $322 Million
Q2 2024 Aug 14, 2024	BUY	$22.0 - $69.71 $71.1 Million - $225 Million	3,233,038 Added 942.58%	3,576,038 $240 Million
Q1 2023 May 15, 2023	BUY	$16.26 - $21.73 $5.25 Million - $7.02 Million	323,050 Added 1619.3%	343,000 $5.85 Million
Q3 2022 Nov 14, 2022	SELL	$20.88 - $28.21 $44.6 Million - $60.3 Million	-2,136,051 Reduced 99.07%	19,950 $430,000
Q4 2020 Feb 16, 2021	SELL	$31.45 - $40.54 $3.67 Million - $4.73 Million	-116,711 Reduced 5.14%	2,156,001 $71.8 Million
Q3 2020 Nov 16, 2020	SELL	$26.0 - $34.5 $19.6 Million - $26 Million	-752,672 Reduced 24.88%	2,272,712 $73 Million
Q1 2020 May 15, 2020	BUY	$13.63 - $33.98 $7.91 Million - $19.7 Million	580,119 Added 23.72%	3,025,384 $48.5 Million
Q4 2019 Feb 14, 2020	BUY	$16.12 - $24.98 $3.47 Million - $5.38 Million	215,505 Added 9.66%	2,445,265 $58.4 Million
Q3 2019 Nov 14, 2019	SELL	$15.49 - $25.78 $3.6 Million - $5.99 Million	-232,456 Reduced 9.44%	2,229,760 $39.3 Million
Q2 2019 Aug 14, 2019	BUY	$23.0 - $32.19 $8.85 Million - $12.4 Million	384,615 Added 18.51%	2,462,216 $63 Million
Q1 2019 May 15, 2019	BUY	$13.91 - $31.15 $3.14 Million - $7.03 Million	225,619 Added 12.18%	2,077,601 $60.4 Million
Q3 2018 Nov 14, 2018	BUY	$18.95 - $28.08 $21.8 Million - $32.3 Million	1,151,982 Added 164.57%	1,851,982 $37.4 Million
Q3 2017 Nov 14, 2017	BUY	$11.61 - $31.21 $8.13 Million - $21.8 Million	700,000	700,000 $21.8 Million

Others Institutions Holding INSM

# of Institutions

579

Shares Held

203M

Call Options Held

2.84M

Put Options Held

3.26M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $19.8B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Bros. Advisors LP with notifications on news.

Account

Baker Bros. Advisors LP Insmed Inc Transaction History